NDC 80425-0300-01 - Bupropion hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0300
- Requested NDC
- 80425-0300-01
- Package NDCs from labels
- 80425-0300-1, 80425-0300-2, 80425-0300-3, 80425-0300-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupropion hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0300-1 | Bupropion hydrochloride | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 2 | |
| 80425-0300-2 | Bupropion hydrochloride | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 2 | |
| 80425-0300-3 | Bupropion hydrochloride | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0300 | BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f8af7829-8b61-6785-e053-6294a90af052.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0300-1 | EA - Each | 80425-0300 | 06c687a0-1094-4799-8d6b-b8ef329ae7fc | 1 | 2023-06-06 |
| 80425-0300-2 | EA - Each | 80425-0300 | 65286faa-05d1-4b75-b630-143099f53618 | 1 | 2023-06-06 |
| 80425-0300-3 | EA - Each | 80425-0300 | 4c1c0dea-98d1-4af5-afb5-3243327e47a0 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 1d722dc2-7909-454e-b989-095677079044 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE (SR) | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 994229b0-e190-49e3-83ce-6a2063f7335a | 2025-07-09 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Coupler LLC | 38f52cec-9534-dab8-e063-6294a90a0704 | 2025-07-02 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | Proficient Rx LP | 1094ff8e-f5a5-4a72-8bf9-25e68f5c964a | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 744f7394-aac9-4864-9436-e5b0b35a6148 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 144379e1-93b7-41c1-bc3a-7bdec5afa309 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | HAWAII REPACK, INC. | b4a1d3b8-afcf-47e3-96d3-469d8f408a31 | 2025-06-11 | Boxed warning, Warnings, Adverse reactions | 993557 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | c5d55b0c-8b81-476a-994e-1989e2a56255 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 9a3b97be-afa3-49e6-962f-662b6807e607 | 2025-06-03 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Coupler LLC | 35a873c5-4aa8-b3c7-e063-6394a90a35ec | 2025-05-21 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | fddc9630-2f9a-4104-888f-3714587d4fe7 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 993541 ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | AvPAK | 2f9c5162-a6c5-e362-e063-6294a90a198d | 2025-03-05 | Boxed warning, Warnings, Adverse reactions | 993557 993541 ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Asclemed USA, Inc. | 637e89e5-8f6e-4392-8045-a778cb9ed138 | 2025-02-12 | Boxed warning, Warnings, Adverse reactions | 993557 ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 5dec4414-5595-46c9-ada9-3fbe98152040 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | ANDA210497 993557 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Coupler LLC | 2ccbf988-64b6-3a60-e063-6394a90ababa | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 993557 ZG7E5POY8O |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | d1043c87-0abe-ee8e-e053-2a95a90a419a | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE SR | BUPROPION HYDROCHLORIDE SR | DirectRx | dd4041cd-00e4-d10f-e053-2a95a90a5945 | 2025-01-22 | Warnings, Adverse reactions | ZG7E5POY8O |
| Bupropion HCL | BUPROPION HCL | Direct_Rx | f820ad7d-3c88-4a4f-e053-6294a90aef7b | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | ZG7E5POY8O |
| BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | DIRECT RX | 96d87edc-d12b-44b2-e053-2995a90a4e63 | 2025-01-22 | Warnings, Adverse reactions | ANDA210497 993557 993541 ZG7E5POY8O |
| Bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 1724f474-d6ab-46af-940f-7f874d4ff7fc | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | 993557 ZG7E5POY8O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.